Status:
COMPLETED
Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Brain Tumor
Eligibility:
All Genders
Brief Summary
This research trial studies electronic medical record review in monitoring the effects of adherence on myelosuppression and morbidity in patients with newly diagnosed brain tumors receiving temozolomi...
Detailed Description
PRIMARY OBJECTIVES: I. Retrospectively measure the frequency of nonadherence with established monitoring guidelines in the target patient population. II. Retrospectively assess the impact of nonadhe...
Eligibility Criteria
Inclusion
- RETROSPECTIVE: All patients seen in Dr. Lesser's clinic who received concurrent temozolomide and radiation therapy followed by adjuvant temozolomide for newly diagnosed malignant gliomas from 01/01/07 through 03/31/2010 will be analyzed
- PROSPECTIVE: All patients seen in Dr. Lesser's clinic who receive concurrent temozolomide and radiation therapy followed by adjuvant temozolomide for newly diagnosed malignant gliomas during and after the construction of the system until the end of the study
Exclusion
- Patients participating in clinical trials or other deviations from non-standard therapies that engender similar monitoring risk will be evaluated for this study on a case by case basis
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 23 2015
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT02208336
Start Date
October 1 2010
End Date
February 23 2015
Last Update
April 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, United States, 27157